L-R: Hiromi Furushima, Takahiro Yanagimoto, Shigehiro Kawase
19 June 2025NewsCareersMarisa Woutersen

Japanese firm adds ex-Norvartis and Alnylam in-house counsel

Former in-house counsel at major pharma companies brings expertise in IP strategy, regulatory compliance, and business development across pharma and biotech.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk